Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of β-catenin

Cancer Research

Volumn 62, Issue 7, 2002, Pages 1971-1977

  Harada, Naomoto ^a   Miyoshi, Hiroyuki ^a   Murai, Naomi ^a   Oshima, Hiroko ^a,b   Tamai, Yoshitaka ^a   Oshima, Masanobu ^a,b   Taketo, Makoto M ^b,c  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; ELECTRON MICROSCOPY; GENE EXPRESSION; GENE MUTATION; HEPATOMEGALY; HISTOLOGY; KNOCKOUT MOUSE; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEPATOMEGALY; INTEGRASES; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOCHONDRIAL SWELLING; MUTATION; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 0036531817     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Wnt signaling: A common theme in animal development
2. Stabilization of β-catenin by genetic defects in melanoma cell lines
3. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
4. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation
5. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β
6. Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor. β-catenin and GSK3β
7. Bridging of β-catenin and glycogen synthase kinase-3β by axin and inhibition of β-catenin-mediated transcription
8. The oncogenic activation of β-catenin
9. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
10. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3
11. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
12. Sporadic medulloblastomas contain oncogenic β-catenin mutations
13. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
14. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
15. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas
16. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
17. Biallelic inactivation of the APC gene in hepatoblastoma
18. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma
19. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma
20. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors
21. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
22. Oncogene-induced liver neoplasia in transgenic mice
23. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human α-1-antitrypsin gene
24. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice
25. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
26. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene
27. Mutations of β-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis
28. β-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam
29. Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae
30. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
31. Optimization of the helper-dependent adenovirus system for production and potency in vivo
32. Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma
33. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma
34. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: A prospective study
35. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene
36. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system
37. Diagnostic tests in liver diseases
38. Identification of c-MYC as a target of the APC pathway
39. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
40. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors
41. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs
42. β-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3FI mice
43. Fine structure of hepatocytes during the etiology of several common pathologies
44. Alcoholic foamy degeneration-a pattern of acute alcoholic injury of the liver
45. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
46. Upregulation of class I major histocompatibility complex antigens by interferon γ is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo
47. Loss of Ape heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene
48. Δ716knockout mice
49. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
50. Hepatomegaly in transgenic mice expressing an oncogenic form of β-catenin
51. An in vivo structure-function study of armadillo, the β-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling